Sorry, we do not have enough data to show an influence graph for this author.
- Full text PDF available (1)
- This year (2)
- Last 5 years (3)
- Last 10 years (3)
Journals and Conferences
The outlook for T-cell malignancies remain poor due to the lack of effective therapeutic options. Chimeric antigen receptor (CAR) immunotherapy has recently shown promise in clinical trials for… (More)
Peripheral T-cell lymphomas (PTCLs) are aggressive lymphomas with no effective upfront standard treatment and ineffective options in relapsed disease, resulting in poorer clinical outcomes as… (More)